"10.1371_journal.pone.0009224","plos one","2010-02-16T00:00:00Z","Yang Zhou; Jayasimha N Murthy; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn","Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, Houston, Texas, United States of America; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas-Houston Medical School, Houston, Texas, United States of America; Graduate School of Biomedical Sciences, University of Texas Health Science Center, Houston, Texas, United States of America; Gilead Sciences, Palo Alto, California, United States of America","Conceived and designed the experiments: YZ MRB. Performed the experiments: YZ. Analyzed the data: YZ MRB. Contributed reagents/materials/analysis tools: JM DZ LB. Wrote the paper: YZ DZ MRB.","Dewan Zeng and Luiz Bellardinelli, co-authors on this manuscript, characterized and supplied the authors with the A2BR antagonist for use in their studies. Both work for Gilead, a company that is developing this antagonist for use in lung disease. This could potentially be viewed as a conflict of interest. This competing interest does not alter the authors adherence to all the Plos ONE policies on sharing data and materials.","2010","02","Yang Zhou","YZ",5,TRUE,2,1,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
